Mölnlycke Health Care annual report 2025 highlights sustainable growth and strategic transformation
Gothenburg, Sweden. 1 April 2026. Today, Mölnlycke Health Care has published its annual report 2025, including sustainability report, outlining the company’s continued focus on revolutionising care for people and planet.
Highlights from the year included:
- 4% organic sales growth, with strong profitability and strengthened market positions.
- Strategic global expansion, including an initiated €115 million investment to expand manufacturing capacity at Brunswick, USA; the commencement of Mölnlycke’s first wound care manufacturing site in China; and ProcedurePak® tray production in Saudi Arabia and Thailand.
- Progress as a sustainability leader, with an EcoVadis platinum rating for the second consecutive year (top 1% globally), validated Net Zero targets and an 18% reduction in greenhouse gas emissions across the entire value chain, compared to 2021 baseline.
- New insights from The 2025 Non-Value Report, highlighting how hospital operating room inefficiencies impact patient safety, staff wellbeing and sustainable healthcare progress.
- Launch of iMpact30+ transformation programme to protect profitability long-term, improve efficiency and build capacity for future investments.
“2025 proved that focused execution and staying close to customers drive results, especially in a turbulent external environment. We’re growing our core business, conquering new markets and transforming how we operate, all while supporting healthcare systems under tremendous pressure to deliver better, more sustainable care,” says Guillaume Joucla, interim CEO, Mölnlycke.
Read the annual report 2025 on www.molnlycke.com/corporate/about/reports/
-Ends-
For more information, please contact:
Jamie Smith
Media Relations Manager
Email jamie.smith@molnlycke,com
Tel.+46 (0)722-553573
About Mölnlycke
Mölnlycke Health Care is a world-leading MedTech company that specializes in innovative solutions for wound care and surgical procedures. Mölnlycke products and solutions are used daily by hospitals, health care providers and patients in over 100 countries around the world. Founded in 1849, Mölnlycke is owned by Investor AB and headquartered in Sweden. www.molnlycke.com
Tags:
